Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma

This publication has 25 references indexed in Scilit:

• Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer
  The Annals of Thoracic Surgery, 2004
• Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma
  The Journal of Thoracic and Cardiovascular Surgery, 2003
• Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer
  International Journal of Radiation Oncology*Biology*Physics, 2002
• Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial
  The Lancet, 2002
• FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
  Lung Cancer, 2002
• An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer
  The Annals of Thoracic Surgery, 2002
• FDG-PET for clinical use
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren1 - Diskussionsbasis der deutschen Konsensus-Konferenz Onko-PET 2000 -
  Pneumologie, 2001
• Prognostic Importance of the Standardized Uptake Value on ¹⁸F-Fluoro-2-Deoxy-Glucose–Positron Emission Tomography Scan in Non–Small-Cell Lung Cancer: An Analysis of 125 Cases
  Journal of Clinical Oncology, 1999
• Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study
  Annals of Oncology, 1998